Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01303-25 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Sunish Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Ertapenem, Bacteremia, Anti-Bacterial Agents, Staphylococcal Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ertapenem combination therapy has been shown to expedite the time to blood culture sterilization among patients with MSSA bacteremia. The purpose of this study was to define what proportion of patients sterilizes blood cultures within 72 h of ertapenem combination treatment initiation. This was a retrospective, multicenter study of patients who received ertapenem combination therapy for MSSA bacteremia. Patients were considered to have rapid blood culture sterilization if blood cultures were negative within 72 h of ertapenem initiation and delayed blood culture sterilization if blood cultures remained positive after 72 h of ertapenem initiation. Of the 304 patients with MSSA bacteremia who received ertapenem for combination treatment, 197 met the inclusion criteria. The median (IQR) time to ertapenem initiation from the time of blood culture obtainment was 4 (3–5) days, and 47% (93/197) had definitive endocarditis. Overall, 85% (167/197) had rapid blood culture sterilization. Patients who had delayed blood culture sterilization had a trend toward a higher Pitt Bacteremia Score at the time of blood culture obtainment (2 [0–4] vs 1 [0-2], P = 0.091) and were more likely to have an oxacillin minimum inhibitory concentration of ≥0.5 µg/mL (67% vs 43%, P = 0.015) compared to those with rapid blood culture sterilization. In this large study of patients who received ertapenem combination therapy for MSSA bacteremia, 85% of patients sterilized their blood cultures within 72 h of treatment. These results suggest that a standard 3-day ertapenem course could be a reasonable stewardship strategy for patients initiated on combination therapy for MSSA bacteremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Pharmacy & Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
- Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Sunish Shah, Ryan K Shields
Zitieren
APA
Shah, S., Clarke, L. G., Falcione, B. A., Shields, R. K., & Smith, B. J. (2026). Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01303-25
Vancouver
Shah S, Clarke LG, Falcione BA, Shields RK, Smith BJ. Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01303-25
BibTeX
@article{Shah2026,
author = {Shah, Sunish and Clarke, Lloyd G and Falcione, Bonnie A and Shields, Ryan K and Smith, Brandon J},
title = {Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01303-25}
}
EUVIMED